217 related articles for article (PubMed ID: 21325486)
1. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue.
Fernandez S; Cisney ED; Hall SI; Ulrich RG
Clin Vaccine Immunol; 2011 Apr; 18(4):667-75. PubMed ID: 21325486
[TBL] [Abstract][Full Text] [Related]
2. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.
Fernandez S; Cisney ED; Ulrich RG
Clin Vaccine Immunol; 2013 Nov; 20(11):1690-6. PubMed ID: 23986319
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
Stiles BG; Garza AR; Ulrich RG; Boles JW
Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.
Sabirov A; Metzger DW
Vaccine; 2008 Mar; 26(12):1566-76. PubMed ID: 18281130
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
8. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines.
Cisney ED; Fernandez S; Hall SI; Krietz GA; Ulrich RG
J Vis Exp; 2012 Aug; (66):3960. PubMed ID: 22871688
[TBL] [Abstract][Full Text] [Related]
9. Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
Pacini MF; Balbi CB; Dinatale B; González FB; Prochetto E; De Hernández MA; Cribb P; Farré C; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
Acta Trop; 2023 May; 241():106889. PubMed ID: 36893830
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.
Heritage PL; Brook MA; Underdown BJ; McDermott MR
Immunology; 1998 Feb; 93(2):249-56. PubMed ID: 9616375
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
[TBL] [Abstract][Full Text] [Related]
12. Characterization of nasal cavity-associated lymphoid tissue in ducks.
Kang H; Yan M; Yu Q; Yang Q
Anat Rec (Hoboken); 2014 May; 297(5):916-24. PubMed ID: 24585532
[TBL] [Abstract][Full Text] [Related]
13. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Abe N; Suzuki M
Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
15. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
16. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.
Wu HY; Nguyen HH; Russell MW
Scand J Immunol; 1997 Nov; 46(5):506-13. PubMed ID: 9393634
[TBL] [Abstract][Full Text] [Related]
17. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)-Structure, function and species differences.
Pabst R
Vaccine; 2015 Aug; 33(36):4406-13. PubMed ID: 26196324
[TBL] [Abstract][Full Text] [Related]
19. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
20. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model.
Hou Y; Hu WG; Hirano T; Gu XX
Vaccine; 2002 May; 20(17-18):2375-81. PubMed ID: 12009294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
